Response Inhibition to High Calorie Food Cues Among Adolescents Following Active and Sedentary Video Game Play
NCT03407352, Not applicable, Completed, Brigham Young University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Response Inhibition to High Calorie Food Cues Among Adolescents Following Active and Sedentary Video Game Play | ClinicalTrials.gov |
| NCT number | NCT03407352 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 65 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Brigham Young University | ClinicalTrials.gov |
| Conditions | Obesity | ClinicalTrials.gov |
| Interventions | Active Video Game Play, Passive Video Game Play | ClinicalTrials.gov |
| First posted | 2018-01-23 | ClinicalTrials.gov |
| Last updated | 2019-02-21 | ClinicalTrials.gov |
Registered outcomes 5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Response inhibition | Immediately within 15 minutes post intervention | Electrical activity of the brain will be recorded using EEG techniques using the Electrical Geodesics amplifier system (EGI: Electrical Geodesics Inc, Eugene OR) during the Go/No Go tasks. The EEG will be recorded continuously with a sampling rate of 250 Hz using a 24-bit analog-to-digital converter. The vertex sensor will be used as the reference electrode. Impedances will be kept below 50 kΩ according to EGI guidelines. A right posterior electrode approximately two inches behind the right mastoid will serve as the common ground. Electroencephalographic data will be segmented off-line and single trial epochs rejected if voltages exceed 100 µV, transitional (sample-to-sample) thresholds were greater than 100 µV or eye-channel amplitudes were above 70 µV. Data will be digitally re-referenced to an average reference then digitally low-pass filtered at 30Hz. | ClinicalTrials.gov |
| Secondary | Memory | Within 45 minutes post intervention | Rey auditory-verbal learning test. After completion of the EEG data recordings and the Stroop color-word test, participants will be asked to complete the Rey auditory verbal learning test (Rey AVLT). The Rey AVLT is often used as part of neuropsychological tests to measure cognitive processes such as learning, interference, retention and retrieval. For the Rey AVLT test researchers will read a list of 15 words and ask participants to repeat back as many words as they can remember. This process will be repeated five times. After the fifth time, researchers will read a new list of 15 words and then ask participants to repeat back as many words from that list as possible. On the 7th trial, researchers will ask participants to repeat as many words from the first list as possible. Participants will be given a 20-minute delay period and then participants will be asked to recall as many words from the first list as possible. | ClinicalTrials.gov |
| Secondary | Hunger | Before and immediately after the intervention | Hunger Ratings. Participants will be asked to rate their hunger at the beginning of each session using a 100-mm visual analogue scale. The visual analogue scale will use six different questions. The six questions will include; 1- how hungry do you feel right now (not at all to extremely) 2- how full do you feel right now (not at all to extremely) 3- how strong is your desire to eat (not at all to extremely) 4- how much do you think you could eat right now (none to extreme amount) 5- what is your urge to eat (extremely low to extremely high) and 6- how much are you thinking about food right now (not at all to constantly). Stubbs et al validated the use and test-retest reliability of visual analogue scales. | ClinicalTrials.gov |
| Secondary | Executive Function | Within 15 minutes post intervention | Stroop Color-Word test. Following the EEG data recordings, participants will complete a Stroop Color-Word test to assess selective attention to task-relevant information and inhibitory control of task-irrelevant information. The Stroop Color-Word test is reliable and commonly used instrument to measure executive function and general response inhibition that contains three parts. First, participants will be asked to read words, printed in black ink, which are names of colors. Second, participants will be asked to name the color of ink patches. Third, participants will be asked to name the color of ink in which the words are printed (i.e., to say "blue" when the word "red" is printed in blue ink). The number of items correctly identified in 45 s after each condition will be recorded and calculated according to previously validated methods. Higher scores indicate the participants responded correctly and had stronger inhibition of task-irrelevant information. | ClinicalTrials.gov |
| Other | Energy Expenditure | This will be measured twice for 60 minutes during each gaming condition | Energy expenditure during passive and active video game play will be measured using K4b2 portable (Cosmed, Rome, Italy) metabolic system, heart rate monitor and activity monitor for both active and sedentary video gaming conditions. The K4b2 portable metabolic system provides indirect calorimetry to determine energy metabolism based off of carbon dioxide production and oxygen consumption. The K4b2 data will be saved on a designated computer for storage and analysis. Previous studies have validated the K4b2 for both prediction accuracy and measurement reliability of metabolic rate compared to other metabolic systems. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 30
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 1986084 | BACKGROUND | PubMed |
| 5328883 | BACKGROUND | PubMed |
| 9020240 | BACKGROUND | PubMed |
| 9700015 | RESULT | PubMed |
| 11103211 | RESULT | PubMed |
| 11345973 | BACKGROUND | PubMed |
| 11842360 | BACKGROUND | PubMed |
| 12127936 | BACKGROUND | PubMed |
| 12853896 | BACKGROUND | PubMed |
| 14589618 | BACKGROUND | PubMed |
| 15973308 | BACKGROUND | PubMed |
| 16869134 | BACKGROUND | PubMed |
| 18606832 | BACKGROUND | PubMed |
| 19409497 | BACKGROUND | PubMed |
| 19596737 | BACKGROUND | PubMed |
| 20155574 | RESULT | PubMed |
| 20440296 | BACKGROUND | PubMed |
| 20603468 | BACKGROUND | PubMed |
| 20850061 | BACKGROUND | PubMed |
| 21616714 | BACKGROUND | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Go/No-Go Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)